New study aims to fill gap in breast cancer treatment for elderly

NCT ID NCT07399808

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how older women (70 years and above) with breast cancer handle CDK4/6 inhibitors, a common targeted therapy. Researchers will track side effects and compare them to younger patients. The goal is to gather real-world data to improve treatment decisions for this often-underrepresented group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CDK4/6 inhibitors

What this could lead to

If successful, this study could help doctors better understand how to safely use CDK4/6 inhibitors in older breast cancer patients, leading to more personalized treatment guidelines.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not change practice immediately, and the small size (100 patients) limits how widely findings can be applied.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    RECRUITING

    Pavia, Pavia, 27100, Italy

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••